-
Emergence and spread of two SARS-CoV-2 variants of interest in Nigeria
-
Persistent SARS-CoV-2 Beta Variant Infection in Patients with Follicular Lymphoma
-
Characterising the magnitude and breadth of T cell responses to SARS-CoV-2 vaccination
-
Seroprevalence of anti-SARS-CoV-2 specific antibodies in vaccinated and vaccine naïve adult Nigerians
-
Implementation, evaluation and use of methods to identify SARS-CoV-2 genetic variants of significance
-
Molecular characterization of interactions between the D614G variant of SARS-CoV-2 S-protein and neutralizing antibodies: A computational approach
-
Fractional order epidemiological model of SARS-CoV-2 dynamism involving Alzheimer’s disease
-
Genomic Surveillance of SARS-CoV-2 in Rio de Janeiro (2020–2021): Temporal Distribution of Viral Variants During the Early Pandemic Genomic Surveillance of SARS-CoV-2 in Brazil
-
Death and ICU Admission Associated with Sars-Cov-2 Variants in Immunocompromised Hospitalised Individuals: A National Observational Study
-
Genomic Surveillance of SARS‐CoV‐2 in Senegal (2020–2024): Variant Turnover, Omicron Introductions, and Interregional Spread
-
An anti-SARS-CoV-2 quantitative study to determine the effect of time on the antibody titre, post-vaccination
-
Multi Epitope-Based Vaccine Design for Protection Against Mycobacterium tuberculosis and SARS-CoV-2 Coinfection
-
SARS‐CoV‐2 Infection, Vaccination Status, and Dementia Risk: A Nested Case–Control Study
-
Low risk of SARS-CoV-2 in blood transfusion
-
Evaluation of two SARS-CoV-2 immunoassays
-
The impact of SARS-CoV-2 on respiratory function
-
Development and Characterization of a Modified Vaccinia Ankara Vaccine Candidate Expressing the SARS-CoV-2 Spike Glycoprotein
-
Using proxy markers from routine diagnostic PCR testing to assess the disease severity of new SARS-CoV-2 variants
-
In vitro and in vivo characterisation of SARS-CoV-2 wildtype, Beta, Delta and Omicron variants of concern : growth kinetics and viral shedding
-
Kinetics of anti-SARS-CoV-2 IgG in saliva and serum post infection, and subsequent vaccination in South Africa
-
Deep mutational scanning of recent SARS-CoV-2 variants highlights changing amino acid preferences within epistatic hotspot residues
-
Investigating SARS-CoV-2 immune responses in children
-
Polymyalgia Rheumatica Post-SARS-CoV-2 Infection
-
Emerging Novel SARS‐CoV‐2 Subvariants and the Advantages of AI‐ML in Deciphering the Mutation Trends, Genomic Surveillance and Vaccine Development
